HER2-Directed Therapies Continue to Shape Improved Breast Cancer Outcomes
Debu Tripathy, MD, provides insights on the management of HER2-positive breast cancer, including the evolving role of trastuzumab in this population.
Source: onclive.com
Stay updated with breaking news from Combat Residual. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Debu Tripathy, MD, provides insights on the management of HER2-positive breast cancer, including the evolving role of trastuzumab in this population.